Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Humoral responses and serological assays in SARS-CoV-2 infections
Y Galipeau, M Greig, G Liu, M Driedger… - Frontiers in …, 2020 - frontiersin.org
In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
We report that in a cohort of 45,965 adults, who were receiving either the ChAdOx1 or the
BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2 …
BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2 …
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
The effectiveness of COVID-19 vaccination in preventing new severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections in the general community is still unclear …
syndrome coronavirus 2 (SARS-CoV-2) infections in the general community is still unclear …
[HTML][HTML] Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re …
Antibody status and incidence of SARS-CoV-2 infection in health care workers
SF Lumley, D O'Donnell, NE Stoesser… - … England Journal of …, 2021 - Mass Medical Soc
Background The relationship between the presence of antibodies to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection …
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: A systematic analysis
Background The infection-fatality ratio (IFR) is a metric that quantifies the likelihood of an
individual dying once infected with a pathogen. Understanding the determinants of IFR …
individual dying once infected with a pathogen. Understanding the determinants of IFR …
[PDF][PDF] Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
KL Bajema, RE Wiegand, K Cuffe, SV Patel… - JAMA internal …, 2021 - jamanetwork.com
Importance Case-based surveillance of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection likely underestimates the true prevalence of infections. Large-scale …
(SARS-CoV-2) infection likely underestimates the true prevalence of infections. Large-scale …
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby… - Medrxiv, 2021 - medrxiv.org
Background REGEN-COV is a combination of 2 monoclonal antibodies (casirivimab and
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV …
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV …
Association of SARS-CoV-2 seropositive antibody test with risk of future infection
RA Harvey, JA Rassen, CA Kabelac… - JAMA internal …, 2021 - jamanetwork.com
Importance Understanding the effect of serum antibodies to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) on susceptibility to infection is important for …
syndrome coronavirus 2 (SARS-CoV-2) on susceptibility to infection is important for …